1. Home
  2. SAIA vs BIO Comparison

SAIA vs BIO Comparison

Compare SAIA & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Saia Inc.

SAIA

Saia Inc.

HOLD

Current Price

$342.88

Market Cap

7.8B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$307.68

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAIA
BIO
Founded
1924
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
8.2B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
SAIA
BIO
Price
$342.88
$307.68
Analyst Decision
Buy
Strong Buy
Analyst Count
17
4
Target Price
$342.59
$358.50
AVG Volume (30 Days)
517.8K
158.4K
Earning Date
10-30-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
10.58
N/A
Revenue
$3,233,286,000.00
$2,557,500,000.00
Revenue This Year
$2.18
$1.77
Revenue Next Year
$4.97
$2.30
P/E Ratio
$32.61
N/A
Revenue Growth
1.96
N/A
52 Week Low
$229.12
$211.43
52 Week High
$545.12
$373.69

Technical Indicators

Market Signals
Indicator
SAIA
BIO
Relative Strength Index (RSI) 73.46 44.85
Support Level $324.61 $307.08
Resistance Level $358.50 $319.50
Average True Range (ATR) 13.83 8.47
MACD 6.34 -1.43
Stochastic Oscillator 85.37 6.82

Price Performance

Historical Comparison
SAIA
BIO

About SAIA Saia Inc.

Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: